000			01948 a2200541 4500
005			20250517233135.0
264		0	_c20181126
008			201811s 0 0 eng d
022			_a1950-6007
024	7		_a10.1016/j.biopha.2018.07.070 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Shanlong
245	0	0	_aEffect of dual mTOR inhibitor on TGFβ1-induced fibrosis in primary human urethral scar fibroblasts. _h[electronic resource]
260			_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cOct 2018
300			_a1182-1187 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCicatrix _xdrug therapy
650	0	4	_aCollagen Type I _xmetabolism
650	0	4	_aCollagen Type I, alpha 1 Chain
650	0	4	_aCollagen Type III _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFibroblasts _xdrug effects
650	0	4	_aFibrosis
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aPhosphorylation
650	0	4	_aPrimary Cell Culture
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aSignal Transduction
650	0	4	_aSirolimus _xpharmacology
650	0	4	_aSmad2 Protein _xmetabolism
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTime Factors
650	0	4	_aTransforming Growth Factor beta1 _xpharmacology
650	0	4	_aTriazines _xpharmacology
650	0	4	_aUrethra _xdrug effects
650	0	4	_aVimentin _xmetabolism
700	1		_aYang, Chuance
700	1		_aLi, Min
700	1		_aWang, Binxian
700	1		_aChen, Hongwei
700	1		_aFu, Delai
700	1		_aChong, Tie
773	0		_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 106 _gp. 1182-1187
856	4	0	_uhttps://doi.org/10.1016/j.biopha.2018.07.070 _zAvailable from publisher's website
999			_c28741204 _d28741204